[
    [
        {
            "time": "",
            "original_text": "易方达一季度新增权益资金853亿元，张坤们拿了这笔钱买了什么？",
            "features": {
                "keywords": [
                    "易方达",
                    "新增权益资金",
                    "张坤",
                    "投资方向"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "基金",
                    "股票"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "易方达一季度新增权益资金853亿元，张坤们拿了这笔钱买了什么？",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 6,
                "Market_Scope": 6,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "华兰生物就新冠疫苗研发、子公司上市进展等情况接受98家机构调研！",
            "features": {
                "keywords": [
                    "华兰生物",
                    "新冠疫苗",
                    "子公司上市",
                    "机构调研"
                ],
                "sentiment_score": 0.85,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "疫苗"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华兰生物就新冠疫苗研发、子公司上市进展等情况接受98家机构调研！",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "",
            "original_text": "“世界第三大酒庄”张坤：五粮液、茅台仍看好 减持洋河股份、泸州老窖 减持股份数量",
            "features": {
                "keywords": [
                    "张坤",
                    "五粮液",
                    "茅台",
                    "洋河股份",
                    "泸州老窖",
                    "减持"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "白酒"
                ],
                "causal_factor": "true",
                "causal_impact": "mixed",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "“世界第三大酒庄”张坤：五粮液、茅台仍看好 减持洋河股份、泸州老窖 减持股份数量",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 9,
                "Duration": 8,
                "Entity_Density": 10,
                "Market_Scope": 4,
                "Time_Proximity": 8,
                "Headline_Structure": 10,
                "Source_Recency": 8
            }
        },
        {
            "time": "",
            "original_text": "平安证券 - - 生物医药行业周报：第五批药品国采数据流出，集采成为常态符合预期【行业研究】",
            "features": {
                "keywords": [
                    "平安证券",
                    "生物医药",
                    "药品国采",
                    "集采常态化"
                ],
                "sentiment_score": 0.5,
                "policy_related": "true",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药",
                    "政策影响"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "平安证券 - - 生物医药行业周报：第五批药品国采数据流出，集采成为常态符合预期【行业研究】",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 9,
                "Entity_Density": 5,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "增量资金集结造势，谁是基金新宠",
            "features": {
                "keywords": [
                    "增量资金",
                    "基金",
                    "新宠"
                ],
                "sentiment_score": 0.75,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "基金",
                    "股票"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "增量资金集结造势，谁是基金新宠",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 6,
                "Duration": 5,
                "Entity_Density": 4,
                "Market_Scope": 8,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]